Immunyx Pharma

Immunyx Pharma
Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
About
What does Immunyx Pharma do?
Immunyx is a drug development company focused on modulating neutrophil function in disease. They are developing a targeted neutrophil nanoparticle platform (TENNs) to address challenges in neutrophil therapy, aiming to provide effective and safe treatments for deregulated neutrophil damage in diseases like COPD, cancer, colitis, and arthritis. Their technology aims to modify neutrophil toxicity without causing neutropenia.
What is Immunyx Pharma's revenue?
StartupHub estimates Immunyx Pharma's annual revenue at $1.0M (range $572K to $1.6M, 64% confidence), based on comparable companies in the sector.
Where is Immunyx Pharma headquartered?
Immunyx Pharma is headquartered in New York, United States.
When was Immunyx Pharma founded?
Immunyx Pharma was founded in 2017.
What industry does Immunyx Pharma operate in?
Immunyx Pharma operates in Life Sciences, Biopharmaceutical, Drug Development, Biotech, MedTech, HealthTech.
How many employees does Immunyx Pharma have?
Immunyx Pharma has approximately 6 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
AI-powered platform for biological research and drug discovery, accelerating scientific breakthroughs.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
